Viatris Inc is voluntarily recalling 110 bottles of Xanax XR (alprazolam) 3 mg extended-release tablets. The recall was initiated because the product failed dissolution testing, which means the medication may not release properly into the body. This issue was identified through low out-of-specification test results for the tablets' ability to dissolve correctly.
If the tablets do not dissolve as designed, the medication may not be fully absorbed, potentially leading to less effective treatment for the patient's condition. No injuries or incidents related to this issue have been reported at this time.
You have 2 options:
Recall #: D-0854-2022
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.